Crystalline forms of pitavastatin calcium

Details for Australian Patent Application No. 2004212160 (hide)

Owner Nissan Chemical Industries Ltd.

Inventors Van Der Schaaf, Paul Adriaan; Schoning, Kai-Uwe; Blatter, Fritz; Szelagiewicz, Martin

Agent Davies Collison Cave

Pub. Number AU-B-2004212160

PCT Pub. Number WO2004/072040

Priority 03405080.7 12.02.03 EP

Filing date 2 February 2004

Wipo publication date 26 August 2004

Acceptance publication date 14 May 2009

International Classifications

A61K 31/47 (2006.01) - Quinolines

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

C07D 215/14 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

Event Publications

4 August 2005 PCT application entered the National Phase

  PCT publication WO2004/072040 Priority application(s): WO2004/072040

10 April 2008 Assignment before Grant

  Ciba Specialty Chemicals Holding Inc. The application has been assigned to Nissan Chemical Industries Ltd.

14 May 2009 Application Accepted

  Published as AU-B-2004212160

17 September 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004212161-Graftable hindered amine light stabilizers

2004212154-Cetylpyridinium salt of an antiinflammatory agent and pharmaceutical compositions containing it